based on 8 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 8 analysts offering long term price targets for Granules India Ltd. An average target of ₹706
Source: S&P Global Market Intelligence
Granules India Ltd price forecast by 8 analysts
Upside of18.21%
High
₹769
Target
₹706.00
Low
₹645
Granules India Ltd target price ₹706, a slight upside of 18.21% compared to current price of ₹590.8. According to 8 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Granules India Ltd revenue growth forecast
Expected growth rate Q1, FY2026:30.42%
Forecast
Actual
Including amortisation and stock based compensations
Granules India Ltd EPS growth forecast
EPS estimate Q1, FY2026:85.05%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 6.61 % |
3 Month Return | + 15.34 % |
1 Year Return | + 79.57 % |
Market Stats | |
Previous Close | ₹597.25 |
Open | ₹596.10 |
Volume | 13.37L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹14,475.47Cr |
P/E Ratio | 29.41 |
PEG Ratio | 12.1 |
Market Cap | ₹14,475.47 Cr |
P/B Ratio | 3.35 |
EPS | 16.72 |
Dividend Yield | 0.35 |
Sector | Pharmaceuticals |
ROE | 15 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹14,475.47 Cr | 84.51% | 0.63 | ₹405 Cr | ₹4,506 Cr | |
HOLD | ₹31,560.96 Cr | 127.13% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹18,791.82 Cr | 30.25% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹6,996.36 Cr | 12.52% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹14,535.09 Cr | 43.59% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Granules India Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Granules India Ltd
Granules India has received USFDA approval for Bupropion Hydrochloride extended-release tablets, enhancing its product portfolio and expanding its presence in the US market. The company now has a total of 67 ANDA approvals. Following the announcement, shares showed a slight increase.
Granules India Announces Executive Leadership Changes - 14 Oct, 2024
Granules India Limited has appointed Mr. Ramraj Rangarajulu as President and Head of Formulations Operations, effective October 14, 2024, succeeding Mr. Anil Arora, who will retire in November 2024.
Granules India Ltd Sees Positive Momentum - 10 Oct, 2024
Granules India Ltd shares rose 1.15% to Rs 580.25, marking a 64.28% increase over the past year. Despite a 14.25% drop in the last month, the stock has gained for three consecutive sessions. The PE ratio stands at 30.9 based on TTM earnings.
Granules India Breaks Key Resistance Level - 04 Oct, 2024
Granules India has surpassed a critical VWAP resistance at Rs590, indicating potential further gains. With an RSI of 50 showing upward momentum, a target of Rs625 is anticipated. Traders are advised to set a stop-loss at Rs580 to manage risks.
Granules India Ltd Continues Upward Trend - 01 Oct, 2024
Granules India Ltd rose 2.52% to Rs 572.65, marking its third consecutive session of gains. The stock has increased 60.7% over the past year, despite a 16.26% decline in the last month. The NIFTY index is down 0.13%.
Granules India Launches Mobile Cancer Screening Initiative - 24 Sep, 2024
Granules India unveiled a Mobile Cancer Screening Unit to improve cancer detection in underserved areas, emphasizing early breast cancer detection and accessible healthcare.
Granules India Faces FDA Violations at Gagillapur Facility - 23 Sep, 2024
Granules India received FDA observations following an inspection at its Gagillapur facility, citing six violations including inadequate cleaning procedures and poor documentation practices. The company must submit a corrective action plan.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 26.62% to 26.78% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 5 quarters, 47.9 Cr → 134.65 Cr (in ₹), with an average increase of 19.7% per quarter
Price Rise
In the last 1 month, GRANULES stock has moved up by 6.6%
Revenue Rich
Revenue is up for the last 3 quarters, 1.15K Cr → 1.18K Cr (in ₹), with an average increase of 1.1% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 49.8%
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 4.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 38.87% of holdings in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 9.16% to 7.86% in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 20.39% to 19.49% in Sep 2024 quarter
This Indian company is the world's largest producer of paracetamol
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 38.87% | 0.00 | |
Foreign Institutions | 19.49% | ||
Mutual Funds | 7.86% | ||
Retail Investors | 26.78% | 0.59 | |
Others | 7.01% | 41.37 |
Granules India Ltd in the last 5 years
Lowest (8.05x)
July 25, 2019
Today (29.41x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (35.36x)
August 30, 2024
Granules India Ltd’s net profit jumped 181.11% since last year same period to ₹134.65Cr in the Q1 2024-2025. On a quarterly growth basis, Granules India Ltd has generated 3.86% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Granules India Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.50%.
Read More about DividendsBearish
Neutral
Bullish
Granules India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Granules India Ltd (GRANULES) share price today is ₹590.8
Granules India Ltd is listed on NSE
Granules India Ltd is listed on BSE
PE Ratio of Granules India Ltd is 29.41
PE ratio = Granules India Ltd Market price per share / Granules India Ltd Earnings per share
Today’s traded volume of Granules India Ltd(GRANULES) is 13.37L.
Today’s market capitalisation of Granules India Ltd(GRANULES) is ₹14475.47Cr.
Granules India Ltd(GRANULES | Price |
---|---|
52 Week High | ₹721 |
52 Week Low | ₹318.95 |
Granules India Ltd(GRANULES) share price is ₹590.8. It is down -18.06% from its 52 Week High price of ₹721
Granules India Ltd(GRANULES) share price is ₹590.8. It is up 85.23% from its 52 Week Low price of ₹318.95
Granules India Ltd(GRANULES | Returns |
---|---|
1 Day Returns | -6.45% |
1 Month Returns | 6.61% |
3 Month Returns | 15.34% |
1 Year Returns | 79.57% |